Research context
Melanotan I is identified in published clinical literature as afamelanotide, an alpha-melanocyte-stimulating hormone analogue studied in controlled photobiology trials.
Areas studied
- Melanocortin receptor pharmacology
- Photobiology
- Pigmentation responses
- Controlled human trials
Limitations and investigational status
The cited trials studied a specific implant formulation in people with erythropoietic protoporphyria. Their findings should not be generalised to other formulations, populations or research materials.
References
For laboratory research use only. Information presented here summarises areas investigated in published research and is not intended as medical advice or as evidence of established effects in humans.